PK Study of Dapagliflozin in Pediatric Subjects With T2DM
Clinical trial NCT01525238 · COMPLETED
Trial details
- NCT number
- NCT01525238
- Sponsor
- AstraZeneca
- Status
- COMPLETED
- Phase
- Phase 1
- Study type
- INTERVENTIONAL
- Start date
- 2012-07-01
- Primary completion
- 2014-09-01
- Enrollment
- 53
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.